arrow_back Back to App

Biotechnology Research Program: Protecting Against Threats and Fostering Innovation

This act establishes a new research program in national laboratories aimed at protecting against biological threats, such as pandemics and other dangers. Through this program, citizens can expect faster responses to health crises and the development of new technologies to enhance security.
Key points
Establishment of a National Biotechnology Program to address long-term biotechnology threats and remaining COVID-19 threats.
Support for biodefense research, including the development of risk assessment and threat detection tools.
Collaboration with academia and industry to accelerate innovation and technology transfer for public benefit.
Increased access to specialized laboratories and equipment for researchers and companies, potentially leading to new discoveries and products.
Planned financial investments in the program to ensure its growth and effectiveness in the coming years.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_S_1624
Sponsor: Sen. Lujan, Ben Ray [D-NM]
Process start date: 2021-05-13
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

National Laboratory Biotechnology Research Act of 2021

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_S_1624.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2021-05-13.

What are the main provisions?

Key points include:

  • Establishment of a National Biotechnology Program to address long-term biotechnology threats and remaining COVID-19 threats.
  • Support for biodefense research, including the development of risk assessment and threat detection tools.
  • Collaboration with academia and industry to accelerate innovation and technology transfer for public benefit.
  • Increased access to specialized laboratories and equipment for researchers and companies, potentially leading to new discoveries and products.
  • Planned financial investments in the program to ensure its growth and effectiveness in the coming years.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Lujan, Ben Ray [D-NM].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-29.

CATEGORIES

Health Security Public Investments